跳至主要内容
临床试验/IRCT20230930059564N1
IRCT20230930059564N1招募中4 期

Investigating the effect of metformin on vascular function and cardiovascular risk factors in children and adolescents with type 1 diabetes: a randomized, double-blind clinical trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
8 years 至 21 years(—)
性别
All

入选标准

  • Age 8 to 21 years
  • Body mass index (BMI) percentile for ages 5 to 85
  • Receiving insulin (Recombinant, NPH, Regular)
  • Not using metformin in the past year
  • Diagnosis of type 1 diabetes (at least 5 years)
  • Not suffering from diabetic ketoacidosis or hypoglycemia (blood sugar level less than 50 mg/dL) in the last 6 months
  • Not using metformin in the past year
  • Not taking anti-hypertensive, anti-inflammatory, anti-coagulant, fat-reducing, weight-reducing and antioxidant drugs in the last 6 months
  • Willingness to participate in the plan

排除标准

  • Pregnant or lactating people
  • Having severe side effects of metformin (lactic acidosis, severe digestive problems)
  • Suffering from endocrine disorders such as hypothyroidism
  • Any acute illness that leads to hospitalization of the patient
  • Lack of compliance (the patient does not want to continue participating in the study for any reason)

研究者

相似试验